Close Menu

NEW YORK ─ Zymo Research said on Wednesday that it has received the CE-IVD mark for its Quick SARS-CoV-2 rRT-PCR kit, enabling its use in the European Union and other countries that accept the designation.

The real-time reverse transcription PCR (rRT-PCR) kit detects SARS-CoV-2 nucleic acids in upper and lower respiratory specimens, and includes ready-to-use reaction mixtures that reduce hands-on time and eliminate human errors during the set-up process enabling results in less than 1.5 hours, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.